In the present study, high-risk patients also had more TH2 cells, which play an important role in tumor survival, while low-risk patients had more CD8 and NK cells, suggesting that immunosuppressive therapies could target the six-gene signature which is associated with the immune microenvironment. The gene discussed is CD8A; the disease is neoplasm.